US 9982261
Antisense antiviral compounds and methods for treating a filovirus infection
granted A61KA61K31/675A61K31/713
Quick answer
US patent 9982261 (Antisense antiviral compounds and methods for treating a filovirus infection) held by Sarepta Therapeutics, Inc. expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/675, A61K31/713, A61P, A61P31/00